Coronary computed tomography angiography (CCTA) has emerged as the preferred modality in the diagnosis of coronary artery disease, but it is limited by modest specificity. By applying principles of computational fluid dynamics, flow fraction reserve, a measure of lesion-specific ischemia that is used to guide revascularization, can be noninvasively derived from CCTA, the so-called computed tomography-derived flow fractional reserve (FFR CT ). The accuracy of FFR CT in discriminating ischemia has been extensively validated, and it has been shown to improve the specificity of CCTA. Compared to other stress myocardial perfusion imaging, FFR CT has superior or comparable accuracy. Clinical studies have provided strong evidence that FFR CT has significant prognostic implications and informs clinical decisions for revascularization, serving as a gatekeeper to invasive coronary angiography. In addition, FFR CT-based tools can be used to simulate the physiological consequences of different revascularization strategies, thus providing the roadmap to achieve complete revascularization. Although challenges remain, ongoing research and randomized controlled trials are expected to address current limitations and better define its role in clinical practice.
outcomes. 6 However, CCTA is limited by modest diagnostic specificity (48%-83%). 2, 3 In particular, coronary calcification and associated blooming and beam-hardening artifacts pose significant challenges to image interpretation. Moreover, CCTA only provides anatomical assessment, which does not inform hemodynamic significance of specific lesions, and, by itself, is therefore a modest guide for interventions. 7 Computed tomography-derived flow fractional reserve (FFR CT ) is a new approach that applies the principles of computational fluid dynamics to CCTA, enabling the development of a 3-dimensional (3-D) pressure map that provides an assessment of the physiological consequences of coronary artery disease. In this article, we review principles, accuracy, and comparative efficacy of FFR CT . We examine its role as the gatekeeper to cardiac catheterization and its utility for revascularization planning. This article concludes with a discussion on future challenges and opportunities.
Computed Tomography-Derived Flow Fractional Reserve: Principles and Accuracy
Flow fractional reserve (FFR) is a physiological measure used to determine the hemodynamic significance of an atherosclerotic lesion, defined as the ratio of the blood pressure distal to the lesion to that of the aorta during adenosineinduced hyperemia. As illustrated in 2 large randomized trials, in contrast to anatomy-based decision-making, 7 FFR can safely and effectively stratify patients into those who would benefit from revascularization and those in whom interventions can be deferred. 8, 9 By applying computational fluid dynamics, it is now possible to derive FFR noninvasively. The scientific principles of FFR CT have been described in detail elsewhere. 10 Briefly, a routine diagnostic CCTA is used to create a patient-specific, 3-D anatomical model of the heart and coronary vasculature, which allows for the development of patient-specific boundary conditions that inform flow and resistance. Anatomical modeling of the myocardium informs ventricular volume and in turn ventricular mass. This allows calculation of coronary flow and meets the myocardial demand at rest, assuming the patient does not have rest angina. Second, based on the anatomical modeling of coronary vasculature, one can quantify microvascular resistance, as it is inversely related to the size of feeding vessels. The next step in the process of FFR CT derivation is to determine changes in microvascular resistance during adenosine-induced hyperemia. This can be simulated without actual infusion of adenosine, as vasodilatory response during maximal hyperemia is predictable. Lastly, by applying the principles of computational fluid Figure 1 . Computed tomography-derived flow fractional reserve findings help to inform the management of a patient with triple vessel disease. CCTA was performed in a 60-year-old gentleman, which showed (A) totally occluded LAD with retrograde collateral filling from LCx, (B) moderate LCx lesion, and (C) severe lesion in RCA. E and F, CCTA findings were confirmed on invasive coronary angiography. Based on FFR CT , LCx lesion (FFR CT ¼ 0.91) was not hemodynamically significant. Thus, instead of thoracotomy and triple coronary artery bypass grafting, it was decided to manage RCA lesion with stenting and LAD with minimally invasive Left internal Mammary Artery (LIMA-LAD) grafting. CCTA indicates coronary computed tomography angiography; FFR CT , computed tomography-derived flow fractional reserve; LAD, left anterior descending artery; LCx, left circumflex artery; RCA, right coronary artery.
dynamics and solving Navier-Stokes equations, a set of nonlinear partial differential equations that describes the motion of noncompressible fluids, one can deduce the pressure at different points along the coronary artery. Navier-Stokes equations are mathematically complex and solving these formulas demands supercomputing power, which necessitates the transmission of CCTA data sets to the core laboratory in HeartFlow Inc (Redwood, California) for processing. The analysis takes 1 to 4 hours. An alternative that aims to simplify the mathematical calculation takes a hybrid approach where reduced-order (1-dimensional) modeling is used for healthy coronary segments and the full 3-D model is reserved for diseased sections. 11 This approach reduces the computing power required substantially and thus allows derivation of FFR using clinical workstations, shortening the processing time to within an hour. Vendors of CT scanners have developed their respective reduced-order FFR CT algorithms with this approach. [12] [13] [14] [15] A clinical example that illustrates the utility of FFR CT is provided in Figure 1 .
Since 2011, multiple clinical studies have validated the accuracy of FFR CT derived both from full 3-D and reducedordered algorithms. [12] [13] [14] [15] [16] [17] [18] [19] [20] Using FFR CT < 0.80 as the cutoff for lesion-specific ischemia, these studies consistently demonstrated a good correlation between FFR CT and invasive FFR. Another consistent finding from these studies is that compared to CCTA, FFR CT has superior diagnostic accuracy in discriminating ischemia. Of note, the prospective, multicenter NXT trial is particularly relevant, as the algorithm studied in this trial (HeartFlow v1.4) is the only one approved for clinical use by the US Food and Drug Administration. In this study, FFR CT has a per-patient sensitivity to identify myocardial ischemia of 86% (95% confidence interval [CI], 77%-92%) and a specificity of 79% (95% CI, 72%-84%), with the area under the receiver operating curve (AUC) of 0.90 (95% CI, 0.87-0.94), and correctly reclassified 68% of patients who have falsepositive CCTAs. 17 Importantly, the diagnostic accuracy remains high in the assessment of intermediate stenosis (30%-70%) and significantly calcified plaques, the 2 most challenging areas of CCTA interpretation. 17, 21 Based on the extensive validation data, the diagnostic accuracy of FFR CT is increasingly accepted, 22 and current research effort is directed toward the comparative efficacy of FFR CT . The Prospective Head-to-Head Comparison of Coronary CT Angiography, Myocardial Perfusion SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease using Fractional Flow Reserve as Index for Functional Severity of Coronary Stenoses study provides the best head-to-head comparison between different noninvasive modalities used to diagnose coronary artery disease. This study enrolled 208 patients investigated for coronary artery disease and showed that FFR CT was excellent in diagnosing vessel-specific ischemia (AUC: 0.94). 23 Moreover, it outperformed CCTA (0.83, P < .001), singlephoton emission computed tomography (SPECT, 0.70, P < .001), and positron emission tomography (PET, 0.87, P < .001). On a per-patient basis, FFR CT (AUC 0.92) also compared favorably to CCTA (0.81, P ¼ .002) and SPECT (0.75, P < .001) and similarly to PET (0.91, P ¼ .56; Figure 2 ).
In addition to established functional studies including SPECT and PET, there has been growing enthusiasm in the development of the computed tomography-based myocardial perfusion (CTP) study, as this technique also has the advantage of providing dual anatomical and functional assessment in one setting. To date, there have been 3 studies that compared the diagnostic utility of FFR CT and CTP. [24] [25] [26] Despite the heterogeneity in FFR CT algorithm (full-or reduced-ordered modeling) and CTP approaches (static or dynamic imaging) used, these studies concordantly showed that FFR CT and CTP have similar diagnostic accuracy. When used in conjunction with CCTA, both provide incremental improvement in diagnostic performance of CCTA, giving an overall AUC of approximately 0.8 to 0.9 ( Figure 2 ). Given the wealth of validation studies (numerous international, multicenter trials) and logistic advantages (no additional radiation, scanning, or pharmacological agents) of FFR CT , investigators have proposed to use FFR CT as the first-line functional assessment. In populations where FFR CT has not been validated (eg, evaluation of stent or graft patency) or where FFR CT analysis is precluded due to suboptimal CCTA image quality, CTP remains a useful tool for the detection of myocardial ischemia (Figure 3 ). 27 
Computed Tomography-Derived Flow Fractional Reserve as the Gatekeeper to Invasive Coronary Angiography and Impacts on Outcomes
In the era of evidence-based medicine, novel diagnostic technologies including FFR CT need to demonstrate that beyond superior diagnostic performance, they also help inform clinical decisionmaking in a fashion that results in improvement in patient outcomes and being cost-effective at the same time. 28 In the Prospective Longitudinal Trial of FFR CT : Outcome and Resource Impacts (PLATFORM) study, the investigators demonstrated that in 380 patients scheduled for invasive coronary angiography, a FFR CT -guided strategy led to reduced referral to cardiac catherization and higher diagnostic yield of invasive coronary angiography. 29, 30 The encouraging result from this pilot study provided impetus for further clinical research. Of note, 2 recently published studies have lent strong support to the clinical utility of FFR CT as a gatekeeper to invasive coronary angiography.
Assessing Diagnostic Value of Non-invasive FFR CT in Coronary CarE (ADVANCE) is a prospective, international, multicenter registry established to examine the real-world utility of FFR CT . This study enrolled 5083 patients with stable symptoms concerning coronary artery disease and CCTA-documented atherosclerosis. Investigators found that FFR CT reclassified and changed the management plan in 66.9% of patients. Further, FFR CT enriches the population referred for invasive coronary angiography. In patients who underwent invasive coronary angiography, those with FFR CT < 0.80 were more likely to have obstructive diseases (finding nonobstructive disease on invasive coronary angiogram, FFR CT <0.80 vs >0.80, 14% vs 44%, P < .001) and to receive revascularization (odds ratio: 5.88, P < .001). 31 Importantly, at 90 days, major adverse cardiac events (MACEs; a composite of death, myocardial infarction, urgent revascularization during unplanned hospitalization for acute coronary syndrome) were much higher in patients with FFR CT < 0.80 (0.6% vs 0%, P < .01). At 1 year, MACE remained numerically higher in patients with FFR CT < 0.80, though this did not reach statistical significance (relative risk ¼ 1.81, 95% CI, 0.96-3.43; P ¼ .06). 32 Moreover, patients with FFR CT > 0.80 experienced fewer ''hard endpoints'' of cardiovascular death and myocardial infarction (0.2% vs 0.8%, P ¼ .01).
The long-term prognostic value of FFR CT was examined by post hoc subanalysis of the NXT study. 33 In 206 individuals who were followed for a median of 4.7 years, it was found FFR CT < 0.80 was associated with worse outcomes, with both higher primary end points (composite of death, myocardial infarction, and revascularization, 73.4% vs 13.4%, P < .001) and secondary end point of MACE (death, myocardial infarction, and unplanned revascularization, 15.6% vs 3.1%, P ¼ .002). Of note, after adjusting for potential confounders, numeric FFR CT (at 0.05 U strata) was shown to be an independent predictor of adverse prognosis (hazard ratio [HR] for primary end point ¼ 1.7, P < .001; for MACE, HR ¼ 1.4, P ¼ .009). Taken together with results from ADVANCE, these studies suggest FFR CT carries significant prognostic implications. Further, it appears physicians opt to defer invasive coronary angiography in patients with FFR CT > 0.80, and the low event rate in this population is a testimony of the safety and efficacy of this approach.
Although these studies provide valuable insights, registry data, and post hoc analyses are inherently limited by their observational nature, nonrandomized design, and selection bias. Thus, these observations remain exploratory. Two studies expected to provide clarity to the clinical utility of FFR CT are currently underway and eagerly awaited.
The Fractional Flow Reserve Derived From Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain (NCT03187639) trial aims to determine the impacts of FFR CT in downstream resource utilization. It is planned that 1400 patients with new-onset chest pain will be randomized to either standard care or CCTA þ FFR CT and followed for 6 months. Downstream use of medications, investigations, and hospital visits will be recorded (primary end point) and data on quality of life and MACE will also be collected (secondary end point).
A second study, the Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization (NCT03702244) trial, investigates whether the incorporation of FFR CT in decision-making alters patient outcomes. This study will randomize 2100 patients with nonacute chest pain into 2 groups. In the usual care group, patients will either have a functional test or proceed directly to invasive coronary angiography. In the second group, the PROMISE score will first be used to screen for patients in whom investigations for coronary artery disease (eg, SPECT) may be safely deferred. In those patients where further testing is indicated, they will be referred for CCTA + FFR CT . The primary outcome is a composite of death, myocardial infarction, and the yield of coronary angiography at 1 year. Additional secondary end points also include quality of life, resource utilization, and radiation exposure.
Utility of FFR CT in Procedural Planning
It has been increasingly recognized that functional incomplete revascularization (defined by residual ischemia after coronary stenting or surgery) has adverse prognostic implications. A subpopulation analysis from the Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention I and II trials showed that a larger improvement in invasive FFR was associated with favorable outcomes and better symptomatic relief. 34 Choi et al found that functional incomplete revascularization is an independent predictor of MACE, with an adjusted HR of 4.17 35 . Thus, effective elimination of ischemia should be the goal of every intervention. To that end, the potential of combined CCTA and FFR CT may provide a roadmap to help plan and guide revascularization in a manner similar to the use of CT prior to implantation of transcatheter aortic valves. To test this hypothesis, Collet et al evaluate the agreement between functional SYNTAX score-a point system used to grade coronary anatomy and guide revascularization strategies-calculated using CCTA and FFR CT and the invasive functional SYNTAX, and these 2 scores were quite similar (21.6 + 7.8 vs 21.2 + 8.8; P ¼ .59). 36 Building on this, the recently published SYNTAX III showed that treatment recommendations (multivessel stenting vs surgery) based on CCTA and FFR CT were in high agreement with those based on invasive investigations (coronary artery bypass surgery recommended in 28% and 26% of patients, respectively, Cohen k 0.82, 95% CI, 0.74-0.91). 37 Similarly, FFR CT can be used to guide percutaneous coronary interventions. By remodeling the stenotic segments with the geometry of a reference segment, the hemodynamic impacts of an intervention can be simulated and used to predict the likelihood of procedural success. This concept was first tested by Kim et al, who demonstrated in a study of 44 patients (48 lesions) that poststenting FFR CT is highly accurate in predicting poststenting residual ischemia (accuracy 96%, sensitivity 100%, specificity 96%). 38 Recently, an interactive planning tool (FFR CT planner) that calculates poststenting FFR CT in real time was developed. This tool allows interventionalists to compare the efficacy of different stenting strategies to formulate a detailed plan down to the number, length, and landing zone of the stents required to achieve best results. In particular, the FFR CT planner may prove most useful in the intervention of serial stenosis. In this setting, the interaction between tandem lesions blunts maximal blood flow during adenosine-induced hyperemia and so invasive FFR measurement of each lesion is unreliable. Consequently, determining ischemia specific to each lesion is challenging and requires complex techniques. In practice, interventionalists usually stent the lesion with larger translesional pressure gradient (DP) during pressure wire pullback, then repeat invasive FFR after stenting to determine residual ischemia and the need for further intervention. Limitations of this approach were illustrated in a study of 24 patients, where Modi Bhavik et al showed that it significantly underestimates the true contribution to ischemia of serial stenoses. 39 These investigators also demonstrated that FFR CT planner can accurately discern the respective contribution to ischemia from each lesion and better predicts residual ischemia following interventions, thus validating its use in clinical practice.
Whether FFR CT will impact clinical decision-making and patient management was tested in the Benefits of Obtaining information for planning With noninvasive FFR CT prior to Invasive Evaluation study. 40 In this study of 101 patients and 327 stenoses, the use of FFR CT planner led to the reclassification and changes to management strategies (optimal medical therapy, stenting, or bypass surgery) in 45% of patients and 31% of lesions. Further, it decreased the need of invasive FFR assessment from 35% to 19%. Although promising, it remains unclear whether decisions based on FFR CT planner lead to better patient care. This hypothesis is being tested in a number of ongoing prospective studies.
Future Challenges and Opportunities
Although FFR CT has made significant inroads into routine clinical practice, challenges remain. In a variable but significant portion (3%-20%) of patients enrolled in clinical studies, FFR CT cannot be performed due to poor image quality. 31, 36 When factors associated with FFR CT rejection were examined, it was found the common most reason for analysis rejection was the presence of motion artifact. Similarly, patient heart rate was an independent predictor of analysis rejection, underscoring the importance of heart rate control. Other adjustable independent predictors of analysis rejection include greater section thickness and field of view, high tube voltage (>120 kVp), and lower aorta contrast opacification. 41 Further research into the optimal setting for CCTA image acquisition may improve the success of FFR CT analysis. Second, in the era of cost containment, funding and reimbursement difficulties pose barriers to adoption of FFR CT . This issue is particular pertinent in single-payer health-care system including Canada and England, where the cost of FFR CT cannot be passed on to patients or insurance companies. In England, this issue is addressed by the competitive Innovation and Technology Payment Programme that aims to promote technologies shown to be clinically effective whose adoption is hindered by financial barriers. More importantly, funding agencies need to consider the cost-effectiveness of FFR CT and its impacts on resource utilization through reduction in downstream investigations. Based on the PLATFORM data, Hlatky et al estimated that savings from avoiding unnecessary invasive coronary angiography would more than offset the cost of FFR CT . 42 With upcoming randomized trials, more cost-benefit analysis can be expected, which should provide further evidence and financial justification for more routine uses of FFR CT . On the other hand, the incorporation of novel technologies, including artificial intelligence, provides opportunities for continuing refinement. The potential of this approach was demonstrated in a multicenter study of 351 patients where a machine learning algorithm was trained to extract and relate 28 variables from the 3-D geometry of the coronary and myocardial anatomy to FFR CT derived from the usual computational fluid dynamic approach. 19 Investigators found that FFR CT derived from machine learning and computational fluid dynamic approach has an almost perfect correlation (r ¼ 0.997) and identical diagnostic performance (AUC 0.84 for both). Remarkably, using this machine learning approach, the processing time was shortened substantially. It can be expected that the application of innovative technologies, including artificial intelligence, will continue to improve diagnostic accuracy while reducing processing time.
Conclusion
For decades, the cardiovascular community has been pursuing diagnostic modalities that are sensitive and specific, inform clinical decision-making, and accurately prognosticate patients. Computed tomography-derived flow fractional reserve presents an exciting opportunity that may fulfill these criteria and change clinical practice. As recent outcome data suggest FFR CT reliably prognosticates and stratifies patients, plays the role as the ''gatekeeper,'' and avoids unnecessary invasive coronary angiography. Looking to the future, FFR CT may be used as a roadmap in preprocedural planning to ensure completeness and precision in revascularization. The promise and potential of FFR CT will be better defined with upcoming clinical trials.
